| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | $2.70M | $2.50M |
| Cost of Revenue | – | – | – | $1.63M | $1.79M |
| Gross Profit | – | – | – | $1.07M | $715.16K |
| Operating Expenses | $3.00M | $1.83M | $437.39K | $2.08M | $1.49M |
| R&D | – | – | – | – | – |
| SG&A | $1.42M | $943.69K | $103.30K | $1.36M | $934.14K |
| Operating Income | -$3.00M | -$1.83M | -$437.39K | -$1.01M | -$772.45K |
| Interest Expense | – | – | $364.27K | $260.27K | $144.96K |
| Tax Expense | – | $14.19K | – | – | – |
| Net Income | -$3.10M | -$785.43K | $246.77K | -$2.06M | -$686.50K |
| EPS (basic) | -0.0200 | -0.0100 | 0.0000 | -0.0300 | -0.0100 |
| EPS (diluted) | -0.0200 | -0.0100 | 0.0000 | -0.0300 | – |
| Shares (diluted) | $135.15M | $101.35M | $83.93M | $74.17M | – |